Diagnostics & Laboratory

Clinical Chemistry Sales: What to Learn First

A practical learning sequence for entering clinical chemistry sales with scientific, operational, and regulatory confidence.

By ROOK Career Resources8 min read
Medical sales professional reviewing clinical chemistry analyzer workflow and laboratory diagnostics materials

Clinical chemistry sales sits at the intersection of laboratory science, diagnostic technology, workflow, and responsible communication. The fastest way to become credible is not to memorize every analyte or instrument feature. Start by understanding how a result travels through a laboratory, what the customer is accountable for, and where your product fits in that process.

This article offers general career guidance for medical and veterinary sales professionals. It does not replace an employer’s training, product labeling, quality procedures, or account-specific policies. Always use the current instructions for use, cleared or approved intended use, and approved commercial materials for the product you represent.

Start with the clinical chemistry workflow, not the catalog

Clinical chemistry involves measurement of chemical components in patient specimens, commonly using automated analyzers, reagents, calibrators, controls, software, and specimen-handling processes. In the human diagnostics setting, these products are generally part of the in vitro diagnostics category: tests performed on specimens taken from the human body. The FDA describes IVDs as including reagents, instruments, and systems intended for diagnostic or health-status purposes. FDA’s overview of IVD regulation is a useful foundational reference.

Before learning a product menu, learn the workflow in order:

  1. Preanalytic work: specimen collection, identification, transport, preparation, and suitability for testing.
  2. Analytic work: the analyzer, assay chemistry, reagents, calibrators, quality control, maintenance, and the measurement process.
  3. Postanalytic work: review, reporting, interfaces, result delivery, troubleshooting documentation, and follow-up.

This structure makes technical conversations easier to follow. It also keeps you from reducing a purchase discussion to a list of test names. A chemistry platform can affect how work enters the laboratory, how exceptions are managed, how staff interact with the system, and how results move onward. Learn to ask where in that chain the account experiences friction before discussing a possible fit.

What to learn first

  • The difference between an analyzer, an assay, a reagent, a calibrator, and a control.
  • The basic meaning of sample types, such as serum, plasma, urine, or whole blood, as applicable to the product.
  • Why specimen condition and handling can affect testing workflows.
  • How routine operation, maintenance, quality control, and troubleshooting are distinct activities.
  • Which parts of the workflow your offering touches directly and which it does not.

You do not need to present yourself as the laboratory’s scientific authority. You do need enough fluency to recognize the right question, avoid unsupported assumptions, and bring in an appropriate applications, service, technical, or clinical resource when needed.

Learn the measurement concepts that make product claims meaningful

Next, build a working vocabulary for analytical performance. This is more valuable than trying to master disease interpretation. In a sales role, your purpose is to understand what an approved product claim means operationally and to communicate it accurately within its labeling.

Start with these concepts:

  • Accuracy and bias: how closely a measurement aligns with an accepted reference or comparison value, and whether it tends to differ in a consistent direction.
  • Precision and imprecision: how consistently a method produces results when testing is repeated.
  • Analytical measuring range: the range over which a method is designed to provide reportable measurement performance.
  • Analytical specificity: the extent to which the method measures the intended analyte rather than being affected by other substances.
  • Interference: a substance or condition that may affect measurement performance.
  • Calibration and quality control: related but separate practices used to establish and monitor method performance.

The FDA’s explanation of IVD premarket review identifies bias, imprecision, analytical specificity, and sensitivity among the performance characteristics evaluated for many IVD submissions. Use that FDA framework as a reason to learn the language carefully, not as a substitute for product-specific evidence.

A practical discipline is to connect every technical statement to its source. Is it in the instructions for use? A cleared or approved product record? A company-approved performance document? If you cannot locate the source or it does not apply to the customer’s intended workflow, pause rather than improvising. This protects the customer, the patient-testing process, and your credibility.

Read the instructions for use before learning competitive talking points

The instructions for use should become one of your primary study documents. Read it with a sales professional’s questions in mind:

  • What is the intended use?
  • Which specimen types and test populations are within scope?
  • What equipment, materials, environmental conditions, and procedural steps are required?
  • What limitations, warnings, and precautions are stated?
  • What maintenance, calibration, control, and troubleshooting activities are described?
  • Which claims are supported, and which claims would go beyond the labeling?

For human IVDs, FDA labeling requirements include the chemical, physical, physiological, or biological principles of the procedure among the information addressed in labeling. FDA’s IVD labeling guidance provides helpful context. The point for a sales professional is straightforward: do not separate the product promise from the conditions under which that promise is supported.

Product training may teach a preferred discovery sequence or demo narrative. That is helpful, but it should come after you understand the boundaries of the product. An effective question is often more valuable than a polished claim: How does your team currently handle this step, and what constraints should any proposed approach respect?

Understand laboratory quality and compliance at a practical level

Customers are not only evaluating whether a test runs. They may be responsible for a quality system that supports reliable, timely results. The CDC describes laboratory quality management systems as part of advancing high-quality testing in clinical settings. CDC’s laboratory quality resources can help new sellers see quality as an everyday operating concern rather than an abstract compliance topic.

For human testing in the United States, learn the basic role of the Clinical Laboratory Improvement Amendments. CMS explains that CLIA regulates laboratory testing performed on human specimens for health assessment or for diagnosing, preventing, or treating disease, and that requirements are based on test-method complexity. CMS’s CLIA overview is the appropriate starting point.

At an introductory level, understand that the distinction between waived and nonwaived testing matters. CMS notes that waived tests are simple tests with a low risk of an incorrect result, while nonwaived testing includes moderate- and high-complexity testing. CMS’s explanation of test complexity can orient your learning.

Do not turn this knowledge into legal or regulatory advice. A sales professional can recognize that an account’s certification status, testing scope, and quality processes may shape implementation conversations. The laboratory, its leadership, and the relevant regulatory or accreditation bodies determine what applies in a specific setting.

Learn the customer’s job before proposing a solution

Clinical chemistry decisions rarely belong to one person alone. Depending on the organization, conversations may involve laboratory leadership, technical specialists, operations, procurement, information technology, finance, clinicians, practice leadership, or service teams. Their priorities can overlap, but they are not identical.

Build discovery around workflow rather than titles. Ask general questions such as:

  • Where does testing occur, and how is work routed?
  • What is the current testing mix and what changes are anticipated?
  • Which workflow steps create delays, manual work, repeat work, or uncertainty?
  • What interfaces, space, utilities, training, or service considerations affect the project?
  • What evidence and internal review process will the organization need?
  • Who needs to evaluate scientific fit, operations, implementation, contracting, and support?

Do not assume every account has the same priorities or approval process. Customer needs, local policies, and employer selling processes vary. Your job is to clarify the decision context, document confirmed needs accurately, and align internal resources without overstating what the system can accomplish.

For veterinary chemistry sales, learn the regulatory and species context separately

Veterinary clinical chemistry is not simply human laboratory sales with animal names substituted. Species, specimen practices, reference approaches, workflow design, product labeling, and customer setting can all change the discussion. Learn the intended species and use conditions for each product rather than assuming that a human-use claim transfers to veterinary practice.

The U.S. regulatory environment also differs. FDA explains that animal medical devices can include certain diagnostic test kits and that animal devices do not undergo the same premarket approval pathway described for human medical devices. FDA’s animal-device overview is an important distinction for veterinary sellers. Some veterinary diagnostic products intended to detect animal disease agents or immunological status may also fall within USDA APHIS guidance. APHIS guidance for veterinary diagnostic products explains that scope.

This is not a reason to make broad regulatory claims in front of customers. It is a reason to verify the exact product, intended use, and market. When a question crosses into regulatory interpretation, escalation is the professional answer.

Create a focused learning plan

A strong first learning plan is layered. Begin with the science and workflow that applies across your territory, then move to the details that are specific to your portfolio and employer.

  1. Map the workflow. Draw the path from specimen arrival through result reporting. Mark where your products, service teams, and software may interact with the process.
  2. Build a plain-language glossary. Define core chemistry, quality, instrument, and informatics terms in language you can use accurately with different stakeholders.
  3. Study one product deeply. Read its instructions for use, intended use, limitations, required materials, maintenance expectations, and approved evidence.
  4. Practice compliant explanations. Explain what the product does, how it is used, and what it does not claim to do. Keep the explanation anchored to approved materials.
  5. Learn the implementation handoff. Understand when to involve applications, technical support, service, project management, or regulatory colleagues.
  6. Review and refine. After customer conversations, note unfamiliar terms, unanswered operational questions, and any point requiring internal follow-up.

The first goal is trustworthy fluency

Clinical chemistry sales expertise grows over time, but the first milestone is achievable: become the person who understands the workflow, uses analytical terms correctly, respects labeling and quality boundaries, and asks useful questions. That foundation supports better discovery, clearer collaboration with laboratory professionals, and more responsible diagnostic conversations.

ROOK Career Resources can help sales professionals organize that learning into practical preparation for laboratory and diagnostics opportunities. Start with the workflow, then add product knowledge and account-specific depth.

Updated Oct 12, 2026

Sources & further reading